24th Feb 2016 10:10
LONDON (Alliance News) - Investment company Levrett PLC on Wednesday said it is continuing to seek an acquisition in the pharmaceutical and biotechnology sector and has appointed a broker.
The company, which floated in December, said it has decided to focus its acquisition sights on firms in the oncology, diabetes, obesity and mental health sectors.
Levrett said it has identified a number of possible acquisition targets and will continue conducting due diligence on these.
It added it has appointed Whitman Howard Ltd as its broker with immediate effect.
Levrett shares were untraded on Wednesday, having last traded at 2.10 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Levrett